Arctic Bioscience AS

Arctic Bioscience AS ROA

The Return on Assets (ROA) of Arctic Bioscience AS (ABS.OL) as of Oct 17, 2026 is -14.41 %. In the previous year, Return on Assets (ROA) was -17.13 % — a change of -15.89% (higher).

ROA

-14.41 %

YoY

-15.89%

Last updated:

In 2025, Arctic Bioscience AS's return on assets (ROA) was -14.41 %, a -15.89% increase from the -17.13 % ROA in the previous year.

The Arctic Bioscience AS ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-3.77 NOK
Jan 1, 2019
-4.84 NOK
Jan 1, 2020
-24.24 NOK
Jan 1, 2021
-12.47 NOK
Jan 1, 2022
-10.38 NOK
Jan 1, 2023
-15.16 NOK
Jan 1, 2024
-17.13 NOK
Jan 1, 2025
-14.41 NOK
The Arctic Bioscience AS ROA history
YEARROAYoY
-14.41 %-15.89%
-17.13 %+13.03%
-15.16 %+46.00%
-10.38 %-16.73%
-12.47 %-48.56%
-24.24 %+401.01%
-4.84 %+28.47%
-3.77 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Arctic Bioscience AS Stock analysis

What does Arctic Bioscience AS do? Arctic Bioscience AS is a biotechnology company headquartered in Orsta, Norway, operating within the Health Care sector. The company focuses on the development, manufacturing, and marketing of marine ingredients derived from herring roe. It completed its initial public offering (IPO) on February 24, 2021. Arctic Bioscience aims to provide effective and healthy therapeutic solutions for individuals with autoimmune disorders through marine membrane lipids. The company is developing HRO350, an investigational drug candidate intended for the treatment of mild-to-moderate psoriasis. Its product portfolio includes Romega, a dietary supplement containing omega-3 fatty acids sourced from herring roe in capsule form, as well as herring caviar oil and herring caviar protein offered to business customers. The company operates through three subsidiaries: Arctic Nutrition AS, Romega AS, and Arctic Biopharma AS. Arctic Bioscience AS is listed on the Oslo Stock Exchange under the ticker symbol ABS.OL and holds the ISIN NO0010859580. The company's activities are centered around leveraging marine resources for health-related applications, with a focus on innovative biotechnology solutions for autoimmune conditions and skin health. Arctic Bioscience AS is one of the most popular companies on Eulerpool.

ROA Details

Understanding Arctic Bioscience AS's Return on Assets (ROA)

Arctic Bioscience AS's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Arctic Bioscience AS's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Arctic Bioscience AS's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Arctic Bioscience AS’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Arctic Bioscience AS stock

Return on Assets (ROA) of Arctic Bioscience AS is -14.41 % in 2025.

Return on Assets (ROA) of Arctic Bioscience AS changed from -17.13 % to -14.41 %, representing a -15.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Arctic Bioscience AS since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Arctic Bioscience AS with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Arctic Bioscience AS

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Arctic Bioscience AS